Pier Capital’s AngioDynamics ANGO Stock Holding History

Pier Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.2M	Sell	795,961 -10,717	-1%	-$160K	1.77%	3
2026 Q2	$10.5M	Buy	806,678 +9,982	+1%	+$114K	1.39%	16
2026 Q1	$9.06M	Buy	796,696 +224,841	+39%	+$2.44M	1.49%	12
2025 Q4	$7.34M	Sell	571,855 -91,357	-14%	-$1.13M	1.17%	37
2025 Q3	$7.41M	Sell	663,212 -31,023	-4%	-$299K	1.16%	34
2025 Q2	$6.89M	Buy	694,235 +200,244	+41%	+$1.96M	1.05%	51
2025 Q1	$4.64M	Buy	+493,991	New	+$5.19M	0.78%	64

Other funds holding ANGO

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Pier Capital's ANGO Position: Q3 2026 in Review

Pier Capital reduced its AngioDynamics (ANGO) stake by 1.3% in Q3 2026, selling an estimated $160K and leaving 795,961 shares worth $12.2M. The position accounts for 1.77% of the portfolio, ranked #3.

Pier Capital first reported a position in ANGO in Q1 2025 and has held it in 7 quarters since. 117 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

Pier Capital held 795,961 shares of AngioDynamics worth $12.2M as of Q3 2026.
Pier Capital sold 10,717 AngioDynamics shares in Q3 2026, an estimated $160K.
AngioDynamics made up 1.77% of Pier Capital's portfolio in Q3 2026, its #3 holding.
Pier Capital first reported a position in AngioDynamics in Q1 2025 and has held it in 7 quarters since.
117 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Pier Capital's 13F filing for Q3 2026, filed 13 Nov 2026.